Reporting antimicrobial susceptibilities and phenotypes of resistance to vancomycin in vancomycin-resistant Enterococcus spp. clinical isolates: A nationwide proficiency study

被引:0
|
作者
Fernandez-Cuenca, Felipe [1 ,2 ,3 ]
Lopez-Hernandez, Inmaculada [1 ,2 ,3 ]
Cercenado, Emilia [4 ,5 ,6 ]
Conejo, Maria Carmen [7 ]
Tormo, Nuria [8 ,9 ]
Gimeno, Concepcion [8 ,9 ]
Pascual, Alvaro [1 ,2 ,3 ,7 ]
机构
[1] Hosp Univ Virgen Macarena, Unidad Clin Enfermedades Infecciosas & Microbiol C, Seville, Spain
[2] Univ Seville, Hosp Univ Virgen Macarena, Inst Biomed Sevilla IBIs, CSIC, Seville, Spain
[3] Inst Salud Carlos III, Spanish Network Res Infect Dis REIPI RD16 0016, Madrid, Spain
[4] Hosp Gen Univ Gregorio Maranon, Serv Microbiol & Enfermedades Infecciosas, Madrid, Spain
[5] Univ Complutense, Fac Med, Dept Med, Madrid, Spain
[6] Ctr Invest Biomed Red Enfermedades Resp, CIBERES, CB06 06 0058, Madrid, Spain
[7] Univ Seville, Dept Microbiol, Seville, Spain
[8] Hosp Gen Valencia, Serv Microbiol, Valencia, Spain
[9] Spanish Soc Clin Microbiol & Infect Dis SEIMC, Qual Control Programme CCS, Valencia, Spain
来源
关键词
Enterococcus spp; Quality control; Vancomycin resistance; Antimicrobial susceptibility; National multicenter study; TEICOPLANIN RESISTANCE; VITEK; 2; EPIDEMIOLOGY; INFECTIONS;
D O I
10.1016/j.eimc.2021.11.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: The ability of Spanish microbiology laboratories to (a) determine antimicrobial suscepti-bility (AS), and (b) correctly detect the vancomycin resistance (VR) phenotype in vancomycin-resistant Enterococcus spp. (VRE) was evaluated.Methods: Three VRE isolates representing the VanA (E. faecium), VanB (E. faecium) and VanC (E. gallinarum) VR phenotypes were sent to 52 laboratories, which were asked for: (a) AS method used; (b) MICs of ampicillin, imipenem, vancomycin, teicoplanin, linezolid, daptomycin, ciprofloxacin, levofloxacin and quinupristin-dalfopristin, and high-level resistance to gentamicin and streptomycin; (c) VR phenotype.Results: (a) The most frequently used system was MicroScan; (b) according to the system, the highest percentage of discrepant MICs was found with gradient strips (21.3%). By antimicrobial, the high-est rates of discrepant MICs ranged 16.7% (imipenem) to 0.7% (linezolid). No discrepant MICs were obtained with daptomycin or levofloxacin. Mayor errors (MEs) occurred with linezolid (1.1%/EUCAST) and ciprofloxacin (5.0%/CLSI), and very major errors (VMEs) with vancomycin (27.1%/EUCAST and 33.3%/CLSI) and teicoplanin (5.7%/EUCAST and 2.3%/CLSI). For linezolid, ciprofloxacin, and vancomycin, discrepant MICs were responsible for these errors, while for teicoplanin, errors were due to a misassignment of the clinical category. An unacceptable high percentage of VMEs was obtained using gradient strips (14.8%), especially with vancomycin, teicoplanin and daptomycin; (c) 86.4% of the centers identified VanA and VanB phenotypes correctly, and 95.0% the VanC phenotype.Conclusion: Most Spanish microbiology laboratories can reliably determine AS in VRE, but there is a significant percentage of inadequate interpretations (warning of false susceptibility) for teicoplanin in isolates with the VanB phenotype.& COPY; 2021 Sociedad Espanola de Enfermedades Infecciosas y Microbiologi & PRIME;a Cli & PRIME;nica. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 50 条
  • [21] Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit
    Peta, M
    Carretto, E
    Barbarini, D
    Zamperoni, A
    Carnevale, L
    Perversi, L
    Pagani, M
    Bonora, MG
    Fontana, R
    Marone, P
    Langer, M
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (02) : 163 - 169
  • [22] Molecular characterisation of vancomycin-resistant Enterococcus isolates in clinical samples from Chile
    Saavedra, G.
    Hormazabal, J.
    Maldonado, A.
    Mota, J.
    Baquero, F.
    Silva, J.
    Del Campo, R.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S164 - S164
  • [23] Bacteriocin production in vancomycin-resistant and vancomycin-susceptible Enterococcus isolates of different origins
    del Campo, R
    Tenorio, C
    Jiménez-Díaz, R
    Rubio, C
    Gómez-Lus, R
    Baquero, F
    Torres, C
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 905 - 912
  • [24] Clonal heterogeneity of clinical isolates of vancomycin-resistant Enterococcus faecium with unique vanS
    Pourshafie, Mohammad R.
    Talebi, Malihe
    Saifi, Mahnaz
    Katouli, Mohammad
    Eshraghi, Saeed
    Kuehn, Inger
    Moellby, Roland
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2008, 13 (05) : 722 - 727
  • [25] Epidemiological profiles and pathogenicity of Vancomycin-resistant Enterococcus faecium clinical isolates in Taiwan
    Lin, Pei-Yun
    Chan, Shang-Yih
    Stern, Arnold
    Chen, Po -Hsiang
    Yang, Hung -Chi
    PEERJ, 2023, 11
  • [26] Vancomycin-resistant Enterococcus faecium in Algeria: phenotypic and genotypic characterization of clinical isolates
    Benamrouche, Nabila
    Guettou, Badia
    Henniche, Fatma Zohra
    Assaous, Farida
    Laouar, Houcine
    Ziane, Hanifa
    Djennane, Fazia
    Tiouit, Djamal
    Bentchouala, Chafia
    Yamouni, Ferroudja
    Rahal, Kheira
    Maamar, Hassiba Tali
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (01): : 95 - 101
  • [27] Determinants of the clinical significance of blood culture isolates of vancomycin-resistant Enterococcus faecium
    Linden, PK
    Kramer, DJ
    Kusne, S
    CRITICAL CARE MEDICINE, 1999, 27 (12) : A117 - A117
  • [28] Antimicrobial Activity of Ceragenins against Vancomycin-Susceptible and -Resistant Enterococcus spp.
    Hacioglu, Mayram
    Yilmaz, Fatima Nur
    Oyardi, Ozlem
    Guzel, Cagla Bozkurt
    Inan, Nese
    Savage, Paul B.
    Dosler, Sibel
    PHARMACEUTICALS, 2023, 16 (12)
  • [29] VANA-MEDIATED VANCOMYCIN-RESISTANT ENTEROCOCCUS SPP IN SEWAGE
    TORRES, C
    REGUERA, JA
    SANMARTIN, MJ
    PEREZDIAZ, JC
    BAQUERO, F
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (03) : 553 - 561
  • [30] Associated antimicrobial resistance in Enterococcus spp. clinical isolates
    Branco Artiaga Kobayashi, Claudia Castelo
    Sadoyama, Geraldo
    Goncalves Vieira, Jose Daniel
    Pimenta, Fabiana Cristina
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2011, 44 (03) : 344 - 348